Special Situations & Event Driven › Sub-category
IPO
15 articles
Indian IPO activity remains robust, with Aastha Spintex adding disclosures related to contingent liabilities and related-party transactions in its ₹170 crore offering, reflecting increased regulatory scrutiny of IPO filings. Simultaneously, Adroit Industries launched an ₹890 million IPO to fund manufacturing expansion, demonstrating ongoing capital expenditure within the sector, despite facing risks associated with export dependency and regulatory challenges. These developments, alongside recent IPO filings from other companies, suggest continued investor interest in Indian equities and a willingness to support growth initiatives, although careful consideration of company-specific risks and evolving regulatory landscapes will be crucial for discerning investment opportunities.
Kusumgar Limited ₹6,500 Million IPO Offer for Sale
Kusumgar Limited proposes an IPO comprising an Offer for Sale of up to ₹6,500 million by promoter shareholders Siddharth Yogesh Kusumgar, Sapna Siddharth Kusumgar, and Siddharth Yogesh Kusumgar HUF.
T
Brainbees Subsidiary Swara Baby Files ₹10,000M IPO
Brainbees Solutions discloses subsidiary Swara Baby Products filed DRHP for ₹10,000M IPO comprising ₹5,000M fresh issue and ₹5,000M offer for sale.
Brainbees holds 76.59% stake in Swara Baby and will
Brainbees Solutions Approves ₹3,000M Swara Baby OFS
Brainbees Solutions Board approves participation in Offer for Sale of up to ₹3,000 million in subsidiary Swara Baby Products Limited's proposed IPO.
Swara Baby will remain a subsidiary of Brainbees So
CSM Technologies Limited IPO Raises ₹146 Crore
CSM Technologies launches IPO of 1.29 crore shares at ₹113 per share to raise ₹145.78 crore for working capital and acquisitions.
Company reported ₹16,552 lakh revenue in 9MFY26 with 18.17% EBITDA mar
Amir Chand Exchanges Q4 FY26 Financial Results Clarification
Amir Chand responded to NSE queries regarding its FY26 financial results submission, clarifying single-segment business and legibility.
Company reported standalone FY26 net profit of ₹764.83 million,
Anthem Biosciences Reports Strong FY26 Results with 15% Revenue Growth
Anthem Biosciences reported 15.2% revenue growth to ₹21,243 million and 31.1% PAT growth to ₹5,918 million in FY26, demonstrating strong financial performance.
The company successfully completed its ₹
Hexagon Nutrition FY26 Results and Board Decisions
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, showing revenue growth and profitability.
Re-appointed KPMSS & Associates as Cost Auditor and B
Hexagon Nutrition Approves FY26 Results Post IPO Listing
Hexagon Nutrition's Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, showing revenue growth and profitability.
The company completed its IPO thr
Chatterbox Technologies FY26 Revenue Up 42%
Chatterbox Technologies reported FY26 revenue growth of 42.46% to ₹84.22 crore with EBITDA up 17.76%.
PAT declined 11.76% in H2 FY26 despite revenue growth, with margins compressing due to expansion c
Standard Surfactants FY26 Net Profit Rises to ₹332.84 Lacs
Standard Surfactants reported audited FY26 results with a net profit of ₹332.84 lacs, up from ₹153.35 lacs in FY25.
A fire incident at the Mandideep spray dryer plant on May 3, 2026, is under assessme
Omnitech FY26 Revenue Up 50%, Profit Jumps 77%
Omnitech Engineering approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting a 50% YoY revenue increase to ₹5,358.12 million and a 77% rise in net
Corona Remedies Reports 17% FY26 Revenue Growth to ₹1,403 Cr
Corona Remedies delivered strong FY25-26 performance with 17.28% revenue growth to ₹1,403.18 Cr and 33.45% PAT growth to ₹199.42 Cr, significantly outperforming IPM growth of 8.59%.
The company succes
Aequs Limited FY26 Standalone Profit Surges to ₹498 Crore
Aequs Limited reported audited standalone net profit of ₹497.99 crore for FY26, a significant improvement from a loss of ₹740.78 crore in FY25.
The company completed its IPO in Q3 FY26, raising ₹6,700
Urban Company FY26 Reports ₹235 Crore Loss Despite 36% Revenue Growth
Urban Company reported a consolidated net loss of ₹234.81 crore in FY26 despite 35.9% revenue growth to ₹1,555.54 crore, driven by strategic investments and increased expenses.
The company completed i
N2N Technologies Open Offer Receives Zero Tenders
Open offer by Harmony Remedies for 40% of N2N Technologies at ₹4.30/share closed with zero equity shares tendered by public shareholders.
Post-offer advertisement published on May 19, 2026, in Financi